PANCREATIC DUCTAL ADENOCARCINOMA (PDAC)
Clinical trials for PANCREATIC DUCTAL ADENOCARCINOMA (PDAC) explained in plain language.
Never miss a new study
Get alerted when new PANCREATIC DUCTAL ADENOCARCINOMA (PDAC) trials appear
Sign up with your email to follow new studies for PANCREATIC DUCTAL ADENOCARCINOMA (PDAC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New antibody combo shows promise against tough cancers
Disease control OngoingThis study tests an experimental antibody called GEN1042, alone or with the cancer drug pembrolizumab (with or without chemotherapy), in people with advanced solid tumors like lung, colon, melanoma, head and neck, or pancreatic cancer. The goal is to see if the treatment is safe …
Matched conditions: PANCREATIC DUCTAL ADENOCARCINOMA (PDAC)
Phase: PHASE1, PHASE2 • Sponsor: Genmab • Aim: Disease control
Last updated May 07, 2026 18:38 UTC
-
Pancreatic cancer study tracks early return after surgery
Knowledge-focused ENROLLING_BY_INVITATIONThis study follows 500 adults with pancreatic cancer who had surgery to remove their tumor. Researchers want to see how often the cancer comes back within the first year, where it returns, and how it is found. No new treatments are given—participants just continue their normal fo…
Matched conditions: PANCREATIC DUCTAL ADENOCARCINOMA (PDAC)
Sponsor: Azienda Ospedaliera di Padova • Aim: Knowledge-focused
Last updated May 26, 2026 05:49 UTC
-
New models aim to forecast pancreatic cancer outcomes
Knowledge-focused ENROLLING_BY_INVITATIONThis study aims to create computer models that predict how long patients with advanced pancreatic cancer might live and how well they respond to chemotherapy. Researchers will use medical images, tissue samples, and genetic information from 100 participants. The goal is to help d…
Matched conditions: PANCREATIC DUCTAL ADENOCARCINOMA (PDAC)
Sponsor: RenJi Hospital • Aim: Knowledge-focused
Last updated May 22, 2026 13:53 UTC